Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy L Jenkins

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Future Medicinal Chemistry|September 23, 2016
Drug discovery and development in the era of Big DataJürgen Bajorath, John Overington, Jeremy L Jenkins, et al.
Proteins|December 10, 2002
Virtual screening to enrich hit lists from high-throughput screening: a case study on small-molecule inhibitors of angiogeninJeremy L Jenkins, Richard Y T Kao, Robert Shapiro
Journal of Chemical Information and Modeling|May 23, 2006
Prediction of biological targets for compounds using multiple-category Bayesian models trained on chemogenomics databasesNidhi, Meir Glick, John W Davies, et al.
Journal of Chemical Information and Modeling|June 17, 2014
Using information from historical high-throughput screens to predict active compoundsSereina Riniker, Yuan Wang, Jeremy L Jenkins, et al.
Biochemical and Biophysical Research Communications|December 14, 2002
Inhibition of mammalian ribonucleases by endogenous adenosine dinucleotidesKapil Kumar, Jeremy L Jenkins, Anwar M Jardine, et al.
Journal of Chemical Information and Modeling|December 6, 2008
Ligand-target prediction using Winnow and naive Bayesian algorithms and the implications of overall performance statisticsFlorian Nigsch, Andreas Bender, Jeremy L Jenkins, et al.
Journal of Chemical Information and Modeling|August 4, 2016
Data-Driven Derivation of an "Informer Compound Set" for Improved Selection of Active Compounds in High-Throughput ScreeningShardul Paricharak, Adriaan P IJzerman, Jeremy L Jenkins, et al.
Journal of Chemical Information and Modeling|February 9, 2007
Clustering and rule-based classifications of chemical structures evaluated in the biological activity spaceAnsgar Schuffenhauer, Nathan Brown, Peter Ertl, et al.
Journal of Cheminformatics|April 20, 2026
ChemScreener: an active learning enabled hit discovery workflow with WDR5 inhibitor case studyLingling Shen, Jian Fang, Lulu Liu, et al.
Biochemistry|September 25, 2003
Unexpected binding mode for 2'-phosphoadenosine-based nucleotide inhibitors in complex with human angiogenin revealed by heteronuclear NMR spectroscopyKenji Tonan, Ping Xu, Jeremy L Jenkins, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Future Medicinal Chemistry|September 23, 2016
Drug discovery and development in the era of Big DataJürgen Bajorath, John Overington, Jeremy L Jenkins, et al.
Proteins|December 10, 2002
Virtual screening to enrich hit lists from high-throughput screening: a case study on small-molecule inhibitors of angiogeninJeremy L Jenkins, Richard Y T Kao, Robert Shapiro
Journal of Chemical Information and Modeling|May 23, 2006
Prediction of biological targets for compounds using multiple-category Bayesian models trained on chemogenomics databasesNidhi, Meir Glick, John W Davies, et al.
Journal of Chemical Information and Modeling|June 17, 2014
Using information from historical high-throughput screens to predict active compoundsSereina Riniker, Yuan Wang, Jeremy L Jenkins, et al.
Biochemical and Biophysical Research Communications|December 14, 2002
Inhibition of mammalian ribonucleases by endogenous adenosine dinucleotidesKapil Kumar, Jeremy L Jenkins, Anwar M Jardine, et al.
Journal of Chemical Information and Modeling|December 6, 2008
Ligand-target prediction using Winnow and naive Bayesian algorithms and the implications of overall performance statisticsFlorian Nigsch, Andreas Bender, Jeremy L Jenkins, et al.
Journal of Chemical Information and Modeling|August 4, 2016
Data-Driven Derivation of an "Informer Compound Set" for Improved Selection of Active Compounds in High-Throughput ScreeningShardul Paricharak, Adriaan P IJzerman, Jeremy L Jenkins, et al.
Journal of Chemical Information and Modeling|February 9, 2007
Clustering and rule-based classifications of chemical structures evaluated in the biological activity spaceAnsgar Schuffenhauer, Nathan Brown, Peter Ertl, et al.
Journal of Cheminformatics|April 20, 2026
ChemScreener: an active learning enabled hit discovery workflow with WDR5 inhibitor case studyLingling Shen, Jian Fang, Lulu Liu, et al.
Biochemistry|September 25, 2003
Unexpected binding mode for 2'-phosphoadenosine-based nucleotide inhibitors in complex with human angiogenin revealed by heteronuclear NMR spectroscopyKenji Tonan, Ping Xu, Jeremy L Jenkins, et al.
Pageof 7